www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / Health

Study: Doctors avoid best diabetes therapy

By Shan Juan | China Daily | Updated: 2017-04-18 07:26

Nearly 67 percent of people with diabetes in China have difficulty keeping their blood glucose within safe levels because of widespread "clinical inertia" - a reluctance to prescribe combination drug therapies that have proved effective in other countries - according to a new study.

Backed by pharmaceutical giant MSD, the study tracked more than 5,000 patients and 237 clinical research centers for almost a year. It is thought to be the largest study ever conducted in China on the treatment of Type 2 diabetes.

The findings were published in the first issue of Science China Life Sciences, an academic journal of the Chinese Academy of Sciences and the National Natural Science Foundation of China.

Research and clinical practice overseas has shown that a combination of the drugs metformin and sitagliptin is effective and safe. Other drugs may also be added for a triple effect.

But clinical inertia in China has undermined effective treatment, according to Wang Jianping, who led the study. Wang is director of diabetes care research at the Third Affiliated Hospital of Sun Yat-Sen University in Guangzhou, Guangdong province.

Many Chinese physicians do not prescribe combination therapies in a timely manner, which leads to patients having excessively high blood glucose levels over a long period, he said. Poor control over time can lead to health problems such as heart disease, as well as damage to the eyes, kidneys or nerves.

Doctors "are reluctant to prescribe combination therapies, largely due to a lack of clinical evidence and treatment consensus" in China, Wang said.

Mu Yiming, a senior diabetes specialist who was part of the study team, said the findings could help bridge the knowledge gap and help develop clinical evidence in China supporting combination drug treatments.

In addition, he said, "We're working closely to integrate the findings into the latest version of the national treatment guideline, which is due very soon".

Xing Xiaoyan, head of endocrinology at China-Japan Friendship Hospital, also stressed the importance of patient education. "It's hard to change behavior, and some patients tend to reject combination drug therapy, citing potential adverse reactions," Xing said.

She said the cost of drugs was a concern for many patients, but the government is helping.

"We've seen the government cover more diabetes treatments under public health insurance," she said.

According to the National Health and Family Planning Commission, China has about 113 million adults with Type 2 diabetes, roughly 25 percent of the global total.

Experts estimate that more than 493 million Chinese are prediabetic, which means their blood glucose levels are too high but not high enough for a diabetes diagnosis.

shanjuan@chinadaily.com.cn

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 欧美精品久久久久久久久大尺度 | 午夜免费片在线观看不卡 | 九九色网 | 爽爽爽爽爽爽爽成人免费观看 | 亚洲 欧美 精品专区 极品 | 成人综合在线视频 | 成人a大片高清在线观看 | 欧美一区二区三区男人的天堂 | 伊人色综合久久天天网蜜月 | 女同日韩互慰互摸在线观看 | 免费人成观看在线网 | 欧美一区二区三区不卡免费 | 国产首页精品 | 黄.www| 在线播放亚洲精品 | 特别福利视频在线观看 | 一本久道综合久久精品 | 黄色三级网络 | 成人亚州 | 中文一区 | 香蕉网站狼人久久五月亭亭 | 日本加勒比视频 | 真人一级毛片免费观看视频 | 色九九视频 | 三级在线网站 | 亚洲精品国产成人 | 9999视频| 三级网站在线免费观看 | 久久99国产精一区二区三区! | 欧美人与zoxxxx另类9 | 国产日韩欧美综合一区二区三区 | 国产精品爱久久久久久久三级 | 欧美日韩综合高清一区二区 | 亚洲视频精品 | 八戒午夜精品视频在线观看 | 91伊人久久| 免费一区二区 | 精品国产高清在线看国产 | 欧美二区视频 | 国产日韩精品一区二区在线观看 | jizjiz日本|